GPT-Rosalind logo
Updated May 2026

Review of GPT-Rosalind

GPT-Rosalind is a specialized OpenAI AI model designed for life sciences research. Inspired by Rosalind Franklin, a DNA pioneer, it targets researchers in biology, chemistry and drug discovery through an early-access program. Access happens via an application form, reserved for academic profiles and qualified labs. The goal is to provide a scientific assistant able to analyze publications, support experimental reasoning and accelerate hypothesis formulation. Free for approved research applicants, commercial pricing has not yet been publicly announced.

4.7/5(58)
en#Research Assistant#AI Assistant#Knowledge base

GPT-Rosalind: Programme d'accès anticipé OpenAI dédié aux chercheurs en biologie, chimie et découverte de médicaments.

Try GPT-Rosalind

Best for

  • Researchers in biology and biotech
  • Drug discovery and chemistry labs
  • PhDs exploring scientific hypotheses
  • Academic centers in life sciences

Not ideal for

  • Mainstream users without a scientific background
  • Common marketing or e-commerce use cases
  • Teams needing immediate deployment without application
  • Projects requiring a stable public API
  • Specialized life sciences model from OpenAI
  • Built for biology research, chemistry and drug discovery
  • Supports scientific reasoning and hypothesis generation
  • Free early-access program for approved researchers
  • Helps analyze publications and knowledge bases
  • Strong scientific brand inspired by Rosalind Franklin
  • ⚠️ Limited general availability, application-only access
  • ⚠️ Initially restricted to qualified researchers in sciences
  • ⚠️ Commercial pricing not public for non-research usage
  • ⚠️ No stable public API or documented integrations

GPT-Rosalind is a strong signal from OpenAI toward the scientific community: a model specifically built for life sciences research, able to support researchers in publication analysis, experimental reasoning and drug discovery. Its name, a tribute to Rosalind Franklin, clearly anchors the project in a serious scientific agenda. Still, this is today an early-access program: general availability is limited, access happens via an application form, and qualified academic or industry researchers in biology, chemistry and drug discovery are prioritized. For these profiles, the opportunity is real and free at this stage, with an assistant tailored to their domain. Conversely, GPT-Rosalind is not a generalist tool: no stable public API, no published commercial pricing, and no intended usage for non-scientific needs. Worth tracking closely if you operate in the life sciences space.

How do I get access to GPT-Rosalind?

Access happens via an application form published by OpenAI on openai.com. You provide your researcher profile, lab or institution and describe your life sciences projects to be evaluated and potentially approved.

Is GPT-Rosalind free?

For now, access is free for approved applicants as part of the early-access program dedicated to research. No specific commercial pricing has been published yet for broader usage.

Who is this model really aimed at?

GPT-Rosalind primarily targets researchers in biology, chemistry and drug discovery, whether in academic or industry settings. Non-scientific profiles or generalist use cases are not the focus of the program.

What kind of tasks can the model help with?

Its current positioning includes support for publication analysis, hypothesis generation, scientific knowledge exploration and experimental design assistance. Precise features evolve along with the program.

Is there an API or integrations?

For now, GPT-Rosalind is positioned as an early-access program with no stable public API and no broadly documented integrations. Usage happens through interfaces provided by OpenAI to approved participants.

⚠️ Disclosure: some links are affiliate links (no impact on your price).